이마티닙
Imatinib is a small-molecule inhibitor of multiple tyrosine kinases, including ABL, c-KIT, and PDGFR-β. It is primarily used as an active pharmaceutical ingredient in targeted cancer therapy.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 152459-95-5
Imatinib mesylate
active pharmaceutical ingredient
N-Desmethyl N-Nitroso Imatinib
nitrosamine impurity reference standard
N-Desmethyl Imatinib
pharmaceutical metabolite standard
4-[(4-methyl-4-oxidopiperazin-4-ium-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
active pharmaceutical ingredient
Oxytetracycline hemicalcium salt
active pharmaceutical ingredient
Rac Nebivolol hydrochloride
active pharmaceutical ingredient
Trans-Tramadol
active pharmaceutical ingredient
1-[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-hydroxy-1-pentanone
active pharmaceutical ingredient
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
KTUFNOKKBVMGRW-UHFFFAOYSA-N
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5